Fusion Pharmaceuticals Inc. Annual Return On Equity in % from 2019 to 2021

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2021.
  • Fusion Pharmaceuticals Inc. Return On Equity for the quarter ending June 30, 2022 was -33.9 %, a 43.1% decline year-over-year.
  • Fusion Pharmaceuticals Inc. annual Return On Equity for 2021 was -31.8 %, a 11.7% increase from 2020.
  • Fusion Pharmaceuticals Inc. annual Return On Equity for 2020 was -36 %, a 159% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2021 -31.8 +4.19 +11.7% Jan 1, 2021 Dec 31, 2021
2020 -36 -97.1 -159% Jan 1, 2020 Dec 31, 2020
2019 61.1 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.